Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study. - Wikidata - awgldk - TriplyDB

Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.

Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.

http://www.wikidata.org/entity/Q39660094

about

Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.Considerations in the development of circulating tumor cell technology for clinical use Clinical significance of serum and urinary HER2/neu protein levels in primary non-muscle invasive bladder cancer Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer.Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer.Circulating Biomarkers in Bladder Cancer.Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirements.Biology, detection, and clinical implications of circulating tumor cells.Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy?Molecular markers in bladder cancer: Novel research frontiers.Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.The promise of circulating tumor cells for precision cancer therapy.Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine.Liquid biopsy: a step forward towards precision medicine in urologic malignancies.Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma.Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies.Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses?Liquid biopsies for surveillance and monitoring treatment response of bladder cancer.Detection of circulating tumor cells in different stages of prostate cancer.Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer.HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas.Epidermal growth factor receptor-targeted immune magnetic liposomes capture circulating colorectal tumor cells efficiently.The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.The landscape of genetics and biomarkers in bladder cancer.Circulating tumor cells in genitourinary tumors.Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer.Improving the CellSearch® system.Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.

P2860

Q26765922-9EF7BCAD-9F1C-47EA-8725-AEC4EA135EF8 Q31118547-3F80E1A8-DB47-44F0-9CD3-41E87F2446EB Q33798322-CE68CAC1-D0B7-4442-B4BC-6E8425760E65 Q34028470-DC6D4D45-9C68-4836-90C8-086A2AC5D4B0 Q35226507-14D6FE92-9AB9-4461-BDE8-D1EF8C4E828C Q35227986-66A7D4DC-4EF4-42A6-A07E-480CEC04CC6D Q35915267-1F2581D6-CECB-461E-8C71-4D2FAF55B149 Q36338628-F90E8AAD-C3BB-4C76-9512-24E3338E63A2 Q36589225-C47066A6-8CEF-4033-81D4-860FED3ADB9A Q36770389-2ECEDCD3-30DB-4D2C-86D9-544BDA488C2D Q37352624-B8046552-D5C2-4F78-9AAA-077D86FE267A Q37406357-8709F402-CD71-45B1-B45D-3302E67E6717 Q37530401-A5E1F4F1-DDF4-42AA-873B-35DE6E1C12CE Q38159963-877D4682-41B4-466A-B21E-1F96C94FFB1B Q38268371-51EF02EB-8148-4C8A-A76E-F08F1BBFB699 Q38508249-76C8A3EC-6023-459C-B7B9-7247ACFBF807 Q38520403-410F2745-8414-4392-9C41-6313CF67259A Q38711439-AB8F0164-60B2-4CBA-82EB-DEEE700FE878 Q38817683-1121CF5B-064F-4AC1-A32E-A26B8DB9E3D8 Q38946859-69E87ED2-ED44-4941-86A7-21B84FD7FAF5 Q38969871-13814D04-F11B-4FBE-BA54-07F37ABBEDB5 Q39031157-1DA63499-7AEE-451C-945D-7D56B248D4BF Q39132961-1BA23F44-EFB7-4277-BFC9-1FB89FE340B4 Q39243268-1D6F049E-7F5F-4F1C-8505-6E7A23419687 Q39775377-B1AE97EC-ACAC-4EF6-BDB8-7439335D17D0 Q41605016-DB351B14-752C-4B02-B850-F9E92C23D7A5 Q41709112-2AF68994-3072-49B2-8682-E50D20302864 Q42343423-0313F0A5-791C-4417-B400-BD52DC5EB7F4 Q42380808-4233B200-0BE8-49A8-899C-8509CDAFB263 Q44174170-283C5BE6-B921-442B-8913-3E91CE544B8B Q47110040-B3C1F36B-AAF2-4005-B51D-F045C9ECB27A Q47183177-FCDF57D7-E251-490C-94F3-39CFB8AF23A5 Q48014457-3531C357-F75C-4B48-B5B6-06F3A2952B98 Q49197514-230101B0-985E-4055-90A1-487EDB725379 Q49220712-88BE87FB-592E-47D3-BB0A-4E6CB9A07F7D Q49479865-A8F77CBD-EF75-4EC8-A7D1-5EF2EB37B773 Q49557521-8517C70A-72C8-41F9-BEAE-8BA6D40E4049 Q50992948-3E65613D-165A-49A1-86C1-791546F42ED8 Q51115531-E37DFF2F-0FA8-462C-A032-B7085391AD60 Q51311867-81705266-C17C-4759-89BD-C24C4C0C80FC

P2860

Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.

http://www.wikidata.org/entity/Q39660094

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prognostic role and HER2 expre ...... stectomy: a prospective study.

@en

Prognostic role and HER2 expre ...... stectomy: a prospective study.

@nl

type

label

Prognostic role and HER2 expre ...... stectomy: a prospective study.

@en

Prognostic role and HER2 expre ...... stectomy: a prospective study.

@nl

prefLabel

Prognostic role and HER2 expre ...... stectomy: a prospective study.

@en

Prognostic role and HER2 expre ...... stectomy: a prospective study.

@nl

P1433

Q39660094-BB583FD0-38B5-4D3D-87C4-69FBFB10B655

P1476

Q39660094-DF6043BC-BF3B-45B7-AFDF-B19D89ECFEB1

P2093

Q39660094-1189D2DD-1216-46EE-BAC4-7E8D5CF889A5

Q39660094-246389F9-5B26-471B-BF5B-8FA35C942584

Q39660094-28B70A1E-A985-4F76-B097-BAF2F080DE45

Q39660094-3D373D47-7FBC-42E6-8540-9574BBEE61AE

Q39660094-41FBACC4-2908-4924-B876-98259B29D7D2

Q39660094-436EAAD7-0EBA-4BB0-AB26-93E3CC604DA1

Q39660094-52C685DE-D74D-4C87-8F2C-84B91BC80C19

Q39660094-7170C7B1-4827-49DA-9F59-540CCFAC27E6

Q39660094-84FEF901-C441-4898-90ED-87C4823CEE79

Q39660094-8D8F1080-319B-4FA8-A8D2-FEE923B13F76

P304

Q39660094-7FEC8649-320B-4FAC-814E-2327798F4AA1

P31

Q39660094-1985A565-E070-4BD6-9207-538031CDCF7E

P356

Q39660094-643167D2-BA62-4D59-9324-4DD5ACE81E80

P407

Q39660094-5BEB5008-2872-4A6B-9635-FC135401DFA9

P433

Q39660094-40A1F7CA-B78D-404A-9E20-06F55F9774F7

P478

Q39660094-5D37C0E8-1E2D-44BB-BC2D-DE9170EA6EB4

P577

Q39660094-50B32BEE-6A4A-4363-84A5-37A89BF6AB88

P698

Q39660094-95671B77-0C2D-4425-ACB3-74D511A81E63

P356

J.EURURO.2012.01.017

P1433

European Urology

P1476

Prognostic role and HER2 expre ...... stectomy: a prospective study.

@en

P2093

Armin Soave

http://www.w3.org/2001/XMLSchema#string

Cornelia Coith

http://www.w3.org/2001/XMLSchema#string

Felix K Chun

http://www.w3.org/2001/XMLSchema#string

Jens Hansen

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

Luis A Kluth

http://www.w3.org/2001/XMLSchema#string

Malgorzata Stoupiec

http://www.w3.org/2001/XMLSchema#string

Margit Fisch

http://www.w3.org/2001/XMLSchema#string

Martin G Friedrich

http://www.w3.org/2001/XMLSchema#string

Michael Rink

http://www.w3.org/2001/XMLSchema#string

P304

810-817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURURO.2012.01.017

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22277196

http://www.w3.org/2001/XMLSchema#string